..Technology Effective for the Destruction of Lung Cancervery impresive indeed!!
Dr. Yasufuku stated that, “Results indicate that the lung lobe exhibiting the tumour absorbed approximately 3.2x more TLD-1433 than the contralateral normal lung. These results support the hypothesis that safety and efficacy of PDT therapy will be enhanced due to improved localization to lung tumours versus healthy lung tissue and the selective irradiation of the cancer lesions by strategic placement of the laser light source. The selectivity data also suggests that when an efficacious level of Rutherrin® is delivered and then light activated, a high kill rate of lung cancer may be achieved in patients. This hypothesis will be tested in future preclinical work using orthotopic animal models and if successful, then tested clinically in a Phase Ib human NSCLC clinical trial.”